Skip to main content
Premium Trial:

Request an Annual Quote

Sony Acquires Microfluidic POC Firm Micronics

NEW YORK (GenomeWeb News) – Sony today announced it has acquired microfluidics-based diagnostic tools firm Micronics for an undisclosed amount.

The deal was done through Sony's wholly-owned US subsidiary Sony Corporation of America and is expected to accelerate Sony's own R&D work in the point-of-care space and to hasten commercialization of Micronics' products.

Founded in 1996, Micronics develops near-patient in vitro products for disease diagnosis, prognosis, and treatment monitoring. Last year, it received a $2.6 million grant from the US Department of Defense for the development of its PanNAT system for point-of-care molecular diagnostic testing of infectious pathogens.

Micronics will remain headquartered in Redmond, Wash., where it will operate as a wholly-owned subsidiary of Sony Corporation of America. Its current management, including President Karen Hedine, will remain with the firm.

"[W]e at Micronics aim to make full use of Sony's superior consumer-based technologies, product development capabilities and capacity to distribute products globally in the development of Micronics' products," Hedine said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more